Cytomegalovirus Retinitis in an ALL child on exclusive chemotherapy treated successfully with intravitreal ganciclovir alone

J Pediatr Hematol Oncol. 2013 Apr;35(3):e118-9. doi: 10.1097/MPH.0b013e31827078ad.

Abstract

A child suffering from acute lymphoblastic leukemia on treatment with exclusive chemotherapy presented with vision-threatening cytomegalovirus (CMV) retinitis in 1 eye. Prompt diagnosis and treatment with 3 weekly doses of 2 mg/0.1 mL intravitreal ganciclovir resulted in successful healing of CMV retinitis with restoration of visual acuity. In children with acute lymphoblastic leukemia on exclusive chemotherapy without hematopoietic stem cell transplantation, CMV retinitis has been reported in only 1 case in literature. This child was treated successfully with intravenous ganciclovir. This report highlights the use of successful intravitreal ganciclovir in pediatric age group to avoid side effects of systemic ganciclovir.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Antiviral Agents / therapeutic use*
  • Child
  • Cytomegalovirus / drug effects
  • Cytomegalovirus / pathogenicity
  • Cytomegalovirus Retinitis / chemically induced
  • Cytomegalovirus Retinitis / drug therapy*
  • Cytomegalovirus Retinitis / virology
  • Ganciclovir / therapeutic use*
  • Humans
  • Male
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / complications
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / virology
  • Prognosis
  • Visual Acuity / drug effects*
  • Vitreous Body / drug effects*

Substances

  • Antiviral Agents
  • Ganciclovir